Assessing the outcomes: What really works?

Orthopedics

Volumn 22, Issue 9, 1999, Pages 823-825

  Bourne, Robert B ^a,b   Rorabeck, Cecil H ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; COST UTILITY ANALYSIS; HIP RADIOGRAPHY; HUMAN; PROSTHESIS FIXATION; QUALITY ADJUSTED LIFE YEAR; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME;

EID: 0032834495     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Laupacis A, Bourne RB, Rorabeck CH, et al. The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg An. 1993; 75:1619-1626.
2. Malchau H, Herberts P, Ahnfeit L. Prognosis of total hip replacement in Sweden. Followup of 92,675 operations performed 1978-1990. Acta Orthop Scand. 1990; 64:497-506.
3. Rorabeck CH, Bourne RB, Laupacis A, et al. A double blind study of 250 cases comparing . cemented to cementless total hip arthroplasty. Cost effectiveness and its impact on health related quality of life. Clin Orthop. 1994; 298:156164.
4. Gartland JJ. Orthopaedic clinical research. Deficiencies in experimental design and determinations of outcome. J Bone Joint Surg Am. 1988; 70:1357-1364.
5. Keller RB. Outcomes research in orthopaedics. Journal of the American Academy of Orthopaedic Surgeons. 1993; 1:122-129.
6. Laupacis A, Rorabeck CH, Bourne RB, Feeny D, Tugwell P, Sim DA. Randomized trials in orthopaedics: Why, how, and when? J Bone Joint Surg Am. 1989; 71:535-543.
7. Naylor CD, Williams JI, Basinski A, Goel V. Technology assessment and cost-effectiveness analysis: misguided guidelines? CMAJ. 1993; 148:921-924.
8. Chalmers TC, Celano P, Sacks HS, Smith H Bias in treatment assignment in controlled clinical trials. N EngI J Mett. 1983; 309:1358-1361.
9. Relman AS. Assessment and accountability. The third revolution in medical care.NEnglJ Med. 1988; 319:21-23.
10. Wennberg JE. Outcomes research, cost containment, and the fear of health care rationing. N Engl J Med. 1990; 323:1202-1204.
11. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment of mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969; 51:737-755.
12. Merle d'Aubigne R, Postel M. Functional results of hip arthroplasty with acrylic prosthesis. J Bone Joint Surg Am. 1954; 36:451-475.
13. Tugwell P, Bombardier C, Buchanan WW, Goldsmith CH, Grace E, Hanna B. The MACTAR patient preference disability questionnaire-an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rhewnatol. 19S7;14:3,446-451.
14. Bergner M, Bobbit RA, Carter WB, Gibson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981; 19:787-805.
15. Guyatt G, Sullivan MJ, Thompson PJ, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. CMAJ. 1985; 1132:919-922.
16. LaupacisA, FeenyD, DetskyAS.Tugwell PX. Tentative guidelines for using clinical and , economic evaluations revised. CMAJ. 1993; 148:927-929. .
17. Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care. 1989; 5:559-575.